Edition:
United Kingdom

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

19.94USD
8:14pm GMT
Change (% chg)

$0.16 (+0.81%)
Prev Close
$19.78
Open
$19.93
Day's High
$20.17
Day's Low
$19.59
Volume
44,152
Avg. Vol
41,473
52-wk High
$28.56
52-wk Low
$12.04

Select another date:

Tue, Dec 5 2017

BRIEF-Medimmune Ventures Sells 133,906 Shares Of G1 Therapeutics Inc's Common Stock On Dec 1

* MEDIMMUNE VENTURES INC REPORTS SALE OF 133,906 SHARES OF G1 THERAPEUTICS INC'S COMMON STOCK ON DEC 1 AT $19.75 PER SHARE - SEC FILING Source text: (http://bit.ly/2iVgOvs) Further company coverage:

BRIEF-G1 Therapeutics And AstraZeneca Enter Clinical Trial Collaboration In Non-Small Cell Lung Cancer

* G1 THERAPEUTICS AND ASTRAZENECA ENTER CLINICAL TRIAL COLLABORATION IN NON-SMALL CELL LUNG CANCER

BRIEF-G1 Therapeutics Inc appoints Barclay (Buck) Phillips as CFO and SVP, corporate development​

* G1 Therapeutics Inc - appoints barclay (buck) phillips as chief financial officer and senior vice president, corporate development​

BRIEF-G1 Therapeutics qtrly ‍loss per share $0.55

* G1 therapeutics reports third quarter 2017 financial results and recent operational highlights

BRIEF-G1 Therapeutics Q2 loss per share $1.09‍​

* G1 Therapeutics reports second quarter 2017 financial results and recent operational highlights

Select another date: